Clinical implications of reinforcement as a determinant of substance use disorders

Annual Review of Psychology

Volumn 55, Issue , 2004, Pages 431-461

  Higgins, Stephen T ^a,b   Heil, Sarah H ^a   Lussier, Jennifer Plebani ^b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Alternative reinforcers; Behavioral economics; Community reinforcement; Contingency managment; Vouchers

Indexed keywords

ADDICTION; HUMAN; PSYCHOLOGICAL ASPECT; REINFORCEMENT; REVIEW; RISK FACTOR;

HUMANS; REINFORCEMENT (PSYCHOLOGY); RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 1842590361     PISSN: 00664308     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.psych.55.090902.142033     Document Type: Article

References (129)

1. Abbott PJ, Weller SB, Delaney HD, Moore BA. 1998. Community reinforcement approach in the treatment of opiate addicts. Am. J. Drug Alcohol Abuse 24:17-30
2. Aigner TG, Balster RL. 1978. Choice behavior in rhesus monkeys: cocaine vs. food. Science 201:534-35
3. Alessi SM, Roll JM, Reilly MR Johanson CE. 2002. Establishment of a diazepam preference in human volunteers following a differential-conditioning history of placebo versus diazepam choice. Exp. Clin. Psychopharmacol. 10(2):77-83
4. Anthony JC, Warner LA, Kessler RC. 1994. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 2(3):244-68
5. Azrin N, Besalel VA. 1980. Job Club Counselor's Manual. Baltimore, MD: Univ. Press
6. Baker F, Johnson MW, Bickel WK. 2003. Delay discounting differs between current and never-smokers across commodities, sign, and magnitudes. J. Abnorm. Psychol. 112:382-92
7. Bickel WK, Amass L, Higgins ST, Badger GJ, Esch RA. 1997a. Effects of adding behavioral treatment to opioid detoxification with buprenorpnine. J. Consult. Clin. Psychol. 65(5):803-10
8. Bickel WK, DeGrandpre RJ. 1996. Modeling drug abuse policy in the behavioral economics laboratory. In Advances in Behavioral Economics, ed. L Green, J Kagel, 3:69-95. New York: Ablex
9. Bickel WK, DeGrandpre RJ, Higgins ST. 1995. The behavioral economics of concurrent drug reinforcers: a review and reanalysis of drug self-administration research. Psychopharmacology 118:250-59
10. Bickel WK, Madden GJ, DeGrandpre RJ. 1997b. Modeling the effects of combined behavioral-pharmacological treatment on cigarette smoking: behavioral-economic analyses. Exp. Clin. Psychopharmacol. 5: 334-43
11. Bickel WK, Marsch LA. 2001. Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction 96:73-86
12. Bickel WK, Odum AL, Madden GJ. 1999. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology 146:447-54
13. Bickel WK, Vuchinich RE, eds. 2000. Reframing Health Behavior Change With Behavioral Economics. Mahwah, NJ: Erlbaum. 416 pp.
14. Bigelow GE, Liebson I. 1973. Behavioral contingencies controlling alcoholics' drinking. Alcoholism 9:24-28
15. Bigelow GE, Silverman K. 1999. Theoretical and empirical foundations of contingency management treatments for drug abuse. See Higgins & Silverman 1999, pp. 15-31
16. Budney AJ, Higgins ST. 1998. Treating Cocaine Addiction: A Community Reinforcement Plus Vouchers Approach. Rockville, MD: NIDA
17. Budney AJ, Higgins ST, Delaney DD, Kent L, Bickel WK. 1991. Contingent reinforcement of abstinence with individuals abusing cocaine and marijuana. J. Appl. Behav. Anal. 24(4):657-65
18. Budney AJ, Higgins ST, Radonovich KJ, Novy PL. 2000. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J. Consult. Clin. Psychol 68(6):1051-61
19. Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, et al. 2001. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch. Gen. Psychiatry 58(8):755-61
20. Carroll KM, Chang G, Behr HM, Clinton B, Kosten TR. 1995. Improving treatment outcome in pregnant, methadone-maintained women: results from a randomized clinical trial. Am. J. Addict. 4:56-59
21. Carroll KM, Sinha R, Nich C, Babuscio T, Rounsaville B J. 2002. Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp. Clin. Psychopharmacol 10(1):54-63
22. Chaloupka FJ, Grossman M, Bickel WK, Saffer H. 1999. Introduction. In The Economic Analysis of Substance Use and Abuse: An Integration of Economic and Behavioral Economic Research, ed. FJ Chaloupka, M Grossman, WK Bickel, H Saffer, pp. 1-12. Chicago, IL: Univ. Chicago Press
23. Chang G, Carroll KM, Behr HM, Kosten TR. 1992. Improving treatment outcome in pregnant opiate-dependent women. J. Subst. Abuse Treat. 9(4):327-30
24. Chutuape MA, Silverman K, Stitzer ML. 1999. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients. Drug Alcohol Depend. 54(1):69-81
25. Comer SD, Collins ED, Fischman MW. 1997. Choice between money and intranasal heroin in morphine-maintained humans. Behav. Pharmacol. 8(8):677-90
26. Comer SD, Collins ED, Wilson ST, Donovan MR, Foltin RW, Fischman MW. 1998. Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Eur. J. Pharmacol. 345(1):13-26
27. Corby EA, Roll JM, Ledgerwood DM, Schuster CR. 2000. Contingency management interventions for treating the substance abuse of adolescents: a feasibility study. Exp. Clin. Psychopharmacol. 8:371-76
28. Correia CJ, Carey KB. 1999. Applying behavioral theories of choice to substance use in a sample of psychiatric outpatients. Psychol. Addict. Behav. 13(3):207-12
29. Correia CJ, Carey KB, Borsari B. 2002. Measuring substance-free and substance-related reinforcement in the natural environment. Psychol. Addict. Behav. 16(1):28-34
30. Correia CJ, Carey KB, Simons J, Borsari BE. 2003. Relationships between binge drinking and substance-free reinforcement in a sample of college students. A preliminary investigation. Addict. Behav. 28(2):361-68
31. Correia CJ, Simons J, Carey KB, Borsari BE. 1998. Predicting drug use: application of behavioral theories of choice. Addict. Behav. 23(5):705-9
32. Crabbe JC. 2002. Genetic contributions to addiction. Annu. Rev. Psychol. 53:435-62
33. Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. 2001. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadonepatients: effects of reinforcer magnitude. Exp. Clin. Psychopharmacol. 9(3):317-25
34. Deneau G, Yanagita T, Seevers MH. 1969. Self-administration of psychoactive substances by the monkey. Psychopharmacology 16(1):30-48
35. Donatelle RJ, Prows SL, Champeau D, Hudson D. 2000. Randomized controlled trial using social support and financial incentives for high risk pregnant smokers: significant other supporter (SOS) program. Tob. Control 9(Suppl. m):67-69
36. Donny EC, Bigelow GE, Walsh SL. 2003. Choosing to take cocaine in the human laboratory: effects of cocaine dose, interchoice interval, and magnitude of alternative reinforcement. Drug Alcohol Depend. 69(3):289-301
37. Donovan DM, Marlatt GA. 1980. Assessment of expectancies and behaviors associated with alcohol consumption. A cognitive-behavioral approach. J. Stud. Alcohol 41(11):1153-85
38. Downey KK, Helmus TC, Schuster CR. 2000. Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance. Exp. Clin. Psychopharmacol. 8(2):176-84
39. Dudish SA, Pentel PR, Hatsukami DK. 1996. Smoked cocaine self-administration in females. Psychopharmacology 123(1):79-87
40. Elk R, Mangus L, Rhoades H, Andres R, Grabowski J. 1998. Cessation of cocaine use during pregnancy: effects of contingency management interventions on maintaining abstinence and complying with prenatal care. Addict. Behav. 23(1):57-64
41. Epstein DH, Hawkins WE, Covi L, Umbricht A, Preston KL. 2003. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-ups. Psychol Addict. Behav. 17(1):73-82
42. Everitt BJ, Dickinson A, Robbins TW. 2001. The neuropsychological basis of addictive behaviour. Brain Res. Brain Res. Rev. 36(2-3):129-38
43. Foltin RW, Fischman MW. 1994. Effect of buprenorphine on the self-administration of cocaine by humans. Behav. Pharmacol. 5(1):79-89
44. Giordano LA, Bickel WK, Loewenstein G, Jacobs EA, Marsch L, Badger GJ. 2002. Mild opioid deprivation increases the degree that opioid-dependent outpatients discount delayed heroin and money. Psychopharmacology 163:174-82
45. Goldberg SR. 1976. The behavioral analysis of drug addiction. In Behavioral Pharmacology, ed. SD Glick, J Goldfarb, pp. 283-316. St. Louis, MO: Mosby
46. Gottlieb AM, Killen JD, Marlatt GA, Taylor CB. 1987. Psychological and pharmacological influences in cigarette smoking withdrawal: effects of nicotine gum and expectancy on smoking withdrawal symptoms and relapse. J. Consult. Clin. Psychol. 55(4):606-8
47. Griffiths RR, Bigelow GE, Liebson I. 1976. Human sedative self-administration: effects of interingestion interval and dose. J. Pharmacol. Exp. Ther. 197(3):488-94
48. Gruber K, Chutuape MA, Stitzer ML. 2000. Reinforcement-based intensive outpatient treatment for inner-city opiate abusers: a short-term evaluation. Drug Alcohol Depend. 57(3):211-23
49. Hart CL, Haney M, Foltin RW, Fischman MW. 2000. Alternative reinforcers differentially modify cocaine self-administration by humans. Behav. Pharmacol. 11(1):87-91
50. Hatsukami DK, Thompson TN, Pentel PR, Flygare BK, Carroll ME. 1994. Self-administration of smoked cocaine. Exp. Clin. Psychopharmacol. 2(2):115-25
51. Heil SH, Tidey JW, Holmes HW, Badger GJ, Higgins ST. 2003. A contingent payment model of smoking cessation: effects on abstinence and withdrawal. Nicotine Tob. Res. 5:205-13
52. Herrnstein RJ. 1970. On the law of effect. J. Exp. Anal. Behav. 13:243-66
53. Higgins ST, Bickel WK, Hughes JR. 1994a. Influence of an alternative reinforcer on human cocaine self-administration. Life Sci. 55:179-87
54. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham R, Badger GJ. 1994b. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch. Gen. Psychiatry 51(7):568-76
55. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G. 1993. Achieving cocaine abstinence with a behavioral approach. Am. J. Psychiatry 150(5):763-69
56. Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, et al. 1991. A behavioral approach to achieving initial cocaine abstinence. Am. J. Psychiatry 148(9):1218-24
57. Higgins ST, Roll JM, Bickel WK. 1996. Alcohol pretreatment increases preference for cocaine over monetary reinforcement. Psychopharmacology 123:1-8
58. Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, et al. 2003. Community reinforcement therapy for cocaine-dependent outpatients. Arch. Gen. Psychiatry. In press
59. Higgins ST, Silverman K, eds. 1999. Motivating Behavior Change Among Illicit Drug Abusers. Washington, DC: APA
60. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL. 2000. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J. Consult. Clin. Psychol. 68(1):64-72
61. Hunt GM, Azrin NH. 1973. A community-reinforcement approach to alcoholism. Behav. Res. Ther. 11(1):91-104
62. Iguchi MY, Belding MA, Morral AR, Lamb RJ, Husband SD. 1997. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J. Consult. Clin. Psychol. 65(3):421-28
63. Johanson CE, Balster RL, Bonese K. 1976. Self-administration of psychomotor stimulant drugs: the effects of unlimited access. Pharmacol. Biochem. Behav. 4(1):45-51
64. Jones HE, Haug N, Silverman K, Stitzer ML, Svikis D. 2001. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend. 61(3):297-306
65. Jones HE, Haug N, Stitzer ML, Svikis D. 2000. Improving treatment outcomes for pregnant drug-dependent women using lowmagnitude voucher incentives. Addict. Behav. 25(2):263-67
66. Katz EC, Chutuape MA, Jones HE, Stitzer ML. 2002a. Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program. Exp. Clin. Psychopharmacol. 10(2):136-43
67. Katz EC, Robles-Sotelo E, Correia CJ, Silverman K, Stitzer ML, Bigelow GE. 2002b. The brief abstinence test: effects of continued incentive availability on cocaine abstinence. Exp. Clin. Psychopharmacol. 10(1):10-17
68. Kirby KC, Marlowe DB, Festinger DS, Garvey KA, La Monaca V. 1999. Community reinforcement training for family and significant others of drug abusers: a unilateral intervention to increase treatment entry of drug users. Drug Alcohol Depend. 56(1):85-96
69. Kirby KC, Marlowe DB, Festinger DS, Lamb RJ, Platt JJ. 1998. Schedule of voucher delivery influences initiation of cocaine abstinence. J. Consult. Clin. Psychol. 66(5):761-67
70. Kirby KN, Petry NM, Bickel WK. 1999. Heroin addicts discount delayed rewards at higher rates than non-drug using controls. J. Exp. Psychol. Gen. 128:78-87
71. MacPhillamy DJ, Lewinsohn PM. 1976. Manual for the Pleasant Events Schedule. Eugene: Univ. Oregon
72. Madden GJ, Petty N, Badger G, Bickel WK. 1997. Impulsive and self-control choices in opioid-dependent subjects and non-drug using controls: drug and monetary rewards. Exp. Clin. Psychopharmacol. 5:256-62
73. Marlatt GA. 1983. The controlled-drinking controversy: a commentary. Am. Psychol. 38(10):1097-110
74. Meyers RJ, Miller WR, Smith JE, Tonigan JS. 2002. A randomized trial of two methods for engaging treatment-refusing drug users through concerned significant others. J. Consult. Clin. Psychol. 70(5):1182-85
75. Meyers RJ, Smith JE. 1995. Clinical Guide to Alcohol Treatment: The Community Reinforcement Approach. New York: Guilford. 211 pp.
76. Miller PM. 1975. A behavioral intervention program for chronic public drunkenness offenders. Arch. Gen. Psychiatry 32:915-18
77. Miller WR, Meyers RJ, Tonigan JS. 1999. Engaging the unmotivated in treatment for alcohol problems: a comparison of three strategies for intervention through family members. J. Consult. Clin. Psychol. 67:688-97
78. Mitchell SH. 1999. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology 146:455-64
79. Odum AL, Madden GJ, Badger GJ, Bickel WK. 2000. Needle sharing in opioid-dependent outpatients: psychological processes underlying risk. Drug Alcohol Depend. 60(3):259-66
80. Pearce DW, ed. 1986. The MIT Dictionary of Modern Economics. Cambridge, MA: MIT Press. 3rd ed.
81. Petry MM. 2001a. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology 154(3):243-50
82. Petry NM. 2001b. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J. Abnorm. Psychol. 110(3):482-87
83. Petry NM. 2002. Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder. Psychopharmacology 162(4):425-32
84. Petry NM, Casarella T. 1999. Excessive discounting of delayed rewards in substance abusers with gambling problems. Drug Alcohol Depend. 56(1):25-32
85. Petry MM, Martin B. 2002. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J. Consult. Clin. Psychol. 70(2):398-405
86. Petry NM, Martin B, Cooney JL, Kranzler HR. 2000. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J. Consult. Clin. Psychol. 68(2):250-57
87. Petry NM, Martin B, Finocche C. 2001. Contingency management in group treatment: a demonstration project in an HTV drop-in center. J. Subst. Abuse Treat. 21(2):89-96
88. Piotrowski NA, Tusel DJ, Sees KL, Reilly PM, Banys P, et al. 1999. Contingency contracting with monetary reinforcers for abstinence from multiple drugs in a methadone program. Exp. Clin. Psychopharmacol. 7(4):399-411
89. Platt DM, Rowlett JK, Spealman RD. 2002. Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology 163(3-4):265-82
90. Poulton R, Caspi A, Milne BJ, Thomson WM, Taylor A, et al. 2002. Association between children's experience of socioeconomic disadvantage and adult health: a life-course study. Lancet 360(9346):1640-45
91. Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. 1999. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend. 54(2):127-35
92. Preston KL, Umbricht A, Epstein DH. 2000. Methadone dose increase and abstinence reinforcement for treatment of continued heroin use during methadone maintenance. Arch. Gen. Psychiatry 57(4):395-404
93. Preston KL, Umbricht A, Epstein DH. 2002. Abstinence reinforcement maintenance contingency and one-year follow-up. Drug Alcohol Depend. 67(2):125-37
94. Preston KL, Umbricht A, Wong CJ, Epstein DH. 2001. Shaping cocaine abstinence by successive approximation. J. Consult. Clin. Psychol 69(4):643-54
95. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, et al. 2002. A comparison of contingency management and cognitivebehavioral approaches during methadone maintenance treatment for cocaine dependence. Arch. Gen. Psychiatry 59(9):817-24
96. Rigsby MO, Rosen MI, Beauvis JE, Cramer JA, Rainey PM, et al. 2000. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J. Gen. Intern. Med. 15:841-47
97. Robles E, Silverman K, Preston KL, Cone EJ, Katz E, et al. 2000. The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug Alcohol Depend. 58(1-2):205-12
98. Robles E, Stitzer ML, Strain EC, Bigelow GE, Silverman K. 2002. Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug Alcohol Depend. 65(2):179-89
99. Roll JM, Higgins ST. 2000. A within-subject comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. Drug Alcohol Depend. 58:103-9
100. Roll JM, Higgins ST, Badger GJ. 1996. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J. Appl. Behav. Anal. 29:495-505
101. Roll JM, Higgins ST, Steingard S, McGinley M. 1998. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Exp. Clin. Psychopharmacol. 6:157-61
102. Roll JM, Reilly MP, Johanson CE. 2000. The influence of exchange delays on cigarette versus money choice: a laboratory analog of voucher-based reinforcement therapy. Exp. Clin. Psychopharmacol. 8(3):366-70
103. Schmilz JM, Rhoades H, Grabowski J. 1995. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients. Addict. Behav. 20(2):171-79
104. Schuster CR, Thompson T. 1969. Self administration of and behavioral dependence on drugs. Annu. Rev. Pharmacol. 9:483-502
105. Shaner A, Roberts LJ, Eckman TA, Tucker DE, Tsuang JW, et al. 1997. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr. Serv. 48(6):807-10
106. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, et al. 2002. Smoking cessation in methadone maintenance. Addiction 97(10):1317-28
107. Sigmon SC, Steingard S, Badger GJ, Anthony SL, Higgins ST. 2000. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Exp. Clin. Psychopharmacol. 8(4):509-17
108. Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. 1996a. Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program. Drug Alcohol Depend. 41(3):197-207
109. Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. 1999. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacologia 146(2):128-38
110. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, et al. 1996b. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch. Gen. Psychiatry 53(5):409-15
111. Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. 2001. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp. Clin. Psychopharmacol. 9(1):14-23
112. Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE. 2002. A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp. Clin. Psychopharmacol. 10(3):228-40
113. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, et al. 1996e. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 41(2):157-65
114. Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL. 1998. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J. Consult. Clin. Psychol. 66(5):811-24
115. Smith JE, Meyers RJ, Delaney HD. 1998. The community reinforcement approach with homeless alcohol-dependent individuals. J. Consult. Clin. Psychol. 66:541-48
116. Sobell MB, Sobell LC. 1973. Alcoholics treated by individualized behavior therapy: one year treatment outcome. Behav. Res. Ther. 11(4):599-618
117. Spragg SDS. 1940. Morphine addiction in chimpanzees. Comp. Psychol. Monogr. 15(7):132
118. Substance Abuse and Mental Health Services Administration. 2002. Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. Off. Appl. Stud., NHSDA Ser. H-17, DHHS Publ. No. SMA 02-3758. Rockville, MD
119. Svikis DS, Lee JH, Haug NA, Stitzer ML. 1997. Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drugdependent women. Drug Alcohol Depend. 48(1):33-41
120. Thompson T, Schuster CR. 1964. Morphine self-administration, food-reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacology 5:87-94
121. Thorndike EL. 1898. Animal intelligence: an experimental study of the associative processes in animals. Psychol. Rev. Mon. Suppl. 2:4
122. Tidey JW, Higgins ST, Bickel WK, Steingard S. 1999. Effects of response requirement and the availability of an alternative reinforcer on cigarette smoking by schizophrenics. Psychopharmacology 145:52-60
123. Tidey JW, O'Neill SC, Higgins ST. 2002. Effects of contingent monetary reinforcement and transdermal nicotine on smoking in schizophrenics. Exp. Clin. Psychopharmacol. 10(3):241-47
124. Van Etten ML, Higgins ST, Budney AJ, Badger GJ. 1998. Comparison of the frequency and enjoyability of pleasant events in cocaine abusers vs. non-abusers using a standardized behavioral inventory. Addiction 93(11):1669-80
125. Vuchinich RE, Simpson CA. 1998. Hyperbolic temporal discounting in social drinkers and problem drinkers. Exp. Clin. Psychopharmacol. 6(3):292-305
126. Walsh SL, Geter-Douglas B, Strain EC, Bigelow GE. 2001. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J. Pharmacol. Exp. Ther. 299(1):147-58
127. Weeks JR. 1962. Experimental morphine addiction: methods for autonomic intravenous injects in unrestrained rats. Science 138:143-44
128. Winett RA. 1973. Parameters of deposit contracts in the modification of smoking. Psychol. Rec. 23(1):49-60
129. Wong CJ, Sheppard JM, Dallery J, Bedient G, Robles E, et al. 2003. Effects of reinforcer magnitude on data-entry productivity in chronically unemployed drug abusers participating in a therapeutic workplace. Exp. Clin. Psychopharmacol. 11(1):46-55